An observational study of haemodynamics with etomidate as an induction agent in patients with coronary artery disease
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 2, Pages 459-468
Abstract
Etomidate has been widely used in western countries has now become available in India. Etomidate ispreferred in patients with CAD, especially with poor left ventricular (LV) function as it provides stable
cardiovascular profile but it has less inhibitory effect on pharyngolaryngeal reflex thus may cause less
blunting of response to laryngoscopy and intubation. After getting approval from institutional ethics
committee, study was carried out in all patients fulfilling the inclusion and exclusion criteria during the
study period. Patient diagnosed or known case of CAD either from history, investigations were
included in the study after obtaining written valid informed consent. There was no hypertension or
hypotension in group A (EF<45%) but in group B (EF>45%) hypertension was noted in just 1 patient
and no hypotension noted. Statistically they were non-significant (p value-0.077). There was no
occurrence any arrhythmias or significant ST changes in either group at any point of time from
induction to 10min after intubation.
Keywords:
- Article View: 92
- PDF Download: 125